Subjective and episodic
Symptoms and self-report are important, but incomplete.
RetinaTek
Making brain performance measurable
RetinaTek is building a task-evoked neurocognitive measurement platform for objective cognitive-performance assessment, research deployments, future recovery-monitoring pathways, and regulated clinical applications after validation and clearance.
Cognitive function affects aging, readiness, recovery, treatment response, safety, and performance. Yet practical measurement still often relies on subjective reports, brief screens, or lengthy specialist evaluations. RetinaTek is building a faster, repeatable way to measure brain performance under controlled cognitive load.
Cognition remains one of healthcare's least measured vital functions
Medicine can measure heart rhythm, blood pressure, oxygen saturation, glucose, imaging, and biomarkers. Cognitive performance is still harder to measure objectively, repeatably, and practically across real-world settings.
Noisy and burdensome
Traditional cognitive tools can be affected by age, education, effort, mood, motor speed, and specialist availability.
Hard to track over time
Clinicians, researchers, and patients need better ways to understand whether performance is stable, improving, or declining.
Task-evoked measurement under controlled cognitive load
RETINA combines controlled cognitive tasks with synchronized eye movements, pupil dynamics, manual responses, and stimulus timing. Instead of simply tracking where the eyes move, RetinaTek measures how the brain controls performance under demand.
Controlled cognitive challenge Multimodal signals Cognitive-performance outputs
Controlled cognitive tasks
Structured challenges place demands on attention, inhibition, working memory, and response control.
Multimodal signals
Eye movements, pupil dynamics, manual responses, and stimulus timing provide complementary views of performance.
Cognitive-performance outputs
RETINA translates task-evoked performance patterns into practical outputs such as Speed, Cognitive Control, and Cognitive Readiness.
Built on a decade-plus evidence base
RETINA emerged from federally funded military and clinical research, with peer-reviewed evidence across attention, cognitive load, performance validity, military TBI, pupillometry, MRI-linked biology, and headset-based deployment.
9+ peer-reviewed studies
Evidence across attention, cognitive load, performance validity, TBI, and pupillometry.
$6M+ federally supported research
Developed through federally funded military and clinical research programs.
Military and clinical research settings
Shaped in research settings where cognitive performance, injury effects, and recovery trajectory have been studied.
MRI-linked biology
Published RETINA-related research has associated task-evoked metrics with DTI white matter findings in military TBI studies.
A staged path from research deployments to regulated clinical markets
RetinaTek separates current research use, near-term commercial cognitive-performance assessment, and future regulated clinical claims. Each pathway has a different purpose, evidence requirement, and claims boundary.
Available now: research and clinical development
Objective neurocognitive endpoints, longitudinal research protocols, usability, workflow, and validation studies.
Discuss research deploymentNear-term commercial: RT-Focus
Supervised cognitive performance assessment for premium care, longevity, cognitive aging, and performance-oriented workflows.
Learn about RT-FocusFuture regulated indications
Future adult and pediatric concussion/mTBI recovery-monitoring claims and adjacent CNS applications after appropriate validation and regulatory clearance.
Review clinical developmentFirst product
RT-Focus
RT-Focus is RetinaTek's first planned product for premium care workflows where patients and members want supervised cognitive performance baselines and repeat measurement over time.
It is being developed for concierge, executive, longevity, preventive health, cognitive-aging, and performance-focused settings. RT-Focus is not positioned as a diagnostic disease test.
Clear claims. Responsible development.
RetinaTek separates research use, cognitive-performance assessment, clinical-development work, and future regulated clinical claims. RT-Focus is a planned supervised cognitive performance assessment and is not positioned as a diagnostic disease test. Disease-specific diagnostic or monitoring claims require appropriate validation and regulatory clearance.
Research use
Available for research and clinical-development deployments under appropriate protocols and agreements.
Cognitive performance
RT-Focus is a planned supervised cognitive performance assessment and is designed for repeat measurement over time.
Future clinical claims
Disease-specific diagnostic or monitoring claims require appropriate validation and regulatory clearance.
Where should you start?
Clinics
Learn about RT-Focus.
ProductResearchers
Discuss research deployment.
ContactClinical-development partners
Review the clinical pathway.
Clinical DevelopmentInvestors and strategic partners
Review the platform thesis.
InvestorsEveryone
Contact the team.
ContactRetinaTek is engaging clinics, researchers, clinical-development partners, strategic collaborators, and investors interested in objective cognitive-performance measurement.